Funded Tech Companies
Regado Biosciences
Regado Biosciences, operating out of San Francisco, received equity investments from Domain Associates, private investors and Baxter Ventures.
Company Overview
Company Name
Regado Biosciences
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
701 Gateway Blvd. 300
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Company Background Information
Overview
Regado (NASDAQ: RGDO) is a spin-out of the Department of Surgery at Duke University Medical Center. Regado's technology enables the rational design of drug-antidote pairs against any target accessible to the bloodstream.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/22/2013
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laurent Fischer
Chief Financial Officer
Christopher Peetz
Chief Medical Officer
Eric Lefebvre
Chief Operating Officer
Helen Jenkins
Company Investors
- Domain Associates (Dennis Podlesak)
- Baxter Ventures
- Valence Life Sciences
- Aurora Funds
- Quaker Partners
- Edmond de Rothschild Investment Partners
- RusnanoMedInvest
- Aurora Funds (Jeffrey Clark)
- Quaker Partners (Sherrill Neff)
- Domain Associates (Jesse Treu)
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs